Regenxbio

RGNX • NASDAQ • Stock Fundamentals

Regenxbio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Curran Simpson, with a market cap of $324.7M.

Market Cap$324.7M

Employees344.0

CEOCurran Simpson

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 1 month agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Regenxbio

Regenxbio (RGNX) has a market capitalization of $324.7M and trades on NASDAQ.

Regenxbio has approximately 344 employees.